PROCESS FOR THE PREPARATION OF 2-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES
    1.
    发明申请
    PROCESS FOR THE PREPARATION OF 2-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES 有权
    制备2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物的方法

    公开(公告)号:US20140350259A1

    公开(公告)日:2014-11-27

    申请号:US14455773

    申请日:2014-08-08

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The invention relates to a novel process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives of formula I or of a salt thereof wherein R1 stands for hydrogen, a halogen, for an optionally protected hydroxyl group or for an optionally protected amino group and R2 is hydrogen or a halogen. 2-Phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives of formula I with their 1,2,4-triazole nucleus build the structural core of a great number of functionalized molecules in medicinal chemistry.

    摘要翻译: 本发明涉及制备式I的2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物或其盐的新方法,其中R1代表氢,卤素,用于 任选保护的羟基或任选保护的氨基,R 2是氢或卤素。 式Ⅰ的2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物与其1,2,4-三唑核构成药物化学中大量官能化分子的结构核心。

    Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives
    5.
    发明授权
    Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives 有权
    制备2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物的方法

    公开(公告)号:US09115130B2

    公开(公告)日:2015-08-25

    申请号:US14455773

    申请日:2014-08-08

    IPC分类号: C07D498/02 C07D471/04

    CPC分类号: C07D471/04

    摘要: The invention relates to a novel process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives of formula I or of a salt thereof wherein R1 stands for hydrogen, a halogen, for an optionally protected hydroxyl group or for an optionally protected amino group and R2 is hydrogen or a halogen. 2-Phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives of formula I with their 1,2,4-triazole nucleus build the structural core of a great number of functionalized molecules in medicinal chemistry.

    摘要翻译: 本发明涉及制备式I的2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物或其盐的新方法,其中R1代表氢,卤素,用于 任选保护的羟基或任选保护的氨基,R 2是氢或卤素。 式Ⅰ的2-苯基 - [1,2,4]三唑并[1,5-a]吡啶衍生物与其1,2,4-三唑核构成药物化学中大量官能化分子的结构核心。